Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-03-02

Clinical Trial Update: A Study of Vinflunine in Patients With Gastric Cancer [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 study of vinflunine in gastric cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vinflunine (vinflunine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Stomach Cancer | Phase 2, Phase 3 | Status: TERMINATED